Literature DB >> 10643298

[Antiinfective drugs into the 21st century].

S Omura1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10643298     DOI： 10.3412/jsb.54.795

Source DB:  PubMed          Journal:  Nihon Saikingaku Zasshi        ISSN： 0021-4930


× No keyword cloud information.
  1 in total

1.  The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis.

Authors:  Nobuhiro Koyama; Yuriko Tokura; Daniela Münch; Hans-Georg Sahl; Tanja Schneider; Yoshio Shibagaki; Haruo Ikeda; Hiroshi Tomoda
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.